{"public_id":"cl_a7484d00bf75392763e563a2fb9bde66","status":"active","superseded_by_public_id":null,"corpus_id":30789930,"text":"Among 466 New York City patients with Mycobacterium tuberculosis isolates tested from April 1991, 33 percent had resistance to one or more antituberculosis drugs, 26 percent had resistance to at least isoniazid, and 19 percent had resistance to both isoniazid and rifampin.","confidence":0.97,"paper":{"corpus_id":30789930,"title":"The emergence of drug-resistant tuberculosis in New York City.","url":"https://sah.borca.ai/papers/30789930"},"contributors":[{"id":35,"public_id":"b2adb6bfad","public_label":"Anonymous (b2adb6bfad)","roles":["extraction"],"url":"https://sah.borca.ai/u/b2adb6bfad"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.97,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":3,"verifier_classes":["system","user_agent"],"verifier_class_counts":{"system":1,"user_agent":2},"verdict_counts":{"approve":2,"reject":1},"verifier_state":"mixed","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_17f10128abd6cbdbd4bb75089b7880c9","name":"antituberculosis drugs","description":"Medications used to treat tuberculosis and assessed for isolate resistance in this paper.","types":["therapeutic agents"],"url":"https://sah.borca.ai/concepts/co_17f10128abd6cbdbd4bb75089b7880c9"},{"public_id":"co_5c2132240a6e1d9a015201777f192aeb","name":"Mycobacterium tuberculosis","description":"The bacterial species cultured from patients and tested for drug susceptibility in this paper.","types":["organism"],"url":"https://sah.borca.ai/concepts/co_5c2132240a6e1d9a015201777f192aeb"},{"public_id":"co_77ea05908791919b9a95524509d853b2","name":"drug-resistant tuberculosis","description":"Tuberculosis involving Mycobacterium tuberculosis isolates resistant to one or more antituberculosis drugs.","types":["condition"],"url":"https://sah.borca.ai/concepts/co_77ea05908791919b9a95524509d853b2"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_a7484d00bf75392763e563a2fb9bde66"}